tiprankstipranks
Ulisse Biomed S.p.A. (DE:8XX)
STUTTGART:8XX

Ulisse Biomed S.p.A. (8XX) Financial Statements

0 Followers

Ulisse Biomed S.p.A. Financial Overview

Ulisse Biomed S.p.A.'s market cap is currently ―. The company's EPS TTM is €-0.184; its P/E ratio is -5.45; Ulisse Biomed S.p.A. is scheduled to report earnings on ―, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22
Income Statement-
Total Revenue-
Gross Profit-
EBIT-
EBITDA-
Net Income Common Stockholders-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 4.44M
Total Assets€ 8.17M
Total Debt€ 89.76K
Net Debt€ -4.35M
Total Liabilities€ 1.45M
Stockholders Equity€ 6.72M
Cash Flow-
Free Cash Flow-
Operating Cash Flow-
Investing Cash Flow-
Financing Cash Flow-
Currency in EUR

Ulisse Biomed S.p.A. Earnings and Revenue History

Ulisse Biomed S.p.A. Debt to Assets

Ulisse Biomed S.p.A. Cash Flow

Ulisse Biomed S.p.A. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis